Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Nippon Zoki Files Twice-Daily Tramadol Sustained-Release Tab. for Chronic Pain
December 16, 2019
- Boehringer Files Ofev in Japan for Progressive Fibrosing Interstitial Lung Disease
December 16, 2019
- 2 Generic Makers List Fosrenol OD Copies after a Legal Win
December 13, 2019
- Keytruda on Track to Become a US$10 Billion Drug in 2019
December 13, 2019
- Lilly Japan Taps Robot to Prod Participation of Children in Clinical Trials
December 13, 2019
- Mulpleta Gets UK’s NICE OK for Thrombocytopenia: Shionogi
December 13, 2019
- Oncolys to Receive 500 Million Yen from Chugai in Telomelysin Milestone
December 13, 2019
- DS-8201 Achieves ORR of 60.9% in Global PII in HER2-Positive Breast Cancer: Daiichi Sankyo/AZ
December 13, 2019
- AnGes Acquiring 30%-Plus Stake in US Genome Editing Biopharma
December 13, 2019
- AstraZeneca, Hitachi to Jointly Research Pathogenesis and Prognosis of COPD
December 12, 2019
- Teribone Autoinjector Hits Shelves
December 12, 2019
- Eisai Set to Renovate Tsukuba Research Laboratories, Aims for Completion by March 2023
December 12, 2019
- Otsuka Pharmaceutical Names Executive Deputy President Inoue as New Chief
December 12, 2019
- Astellas Charging Ahead with Immuno-Oncology Initiative to Save Non-Responders: Chief
December 11, 2019
- Adcetris Posts Positive Follow-Up Data for 1st-Line Use: Takeda/Seattle Genetics
December 11, 2019
- Maruho Grabs Japan Sales Rights to Peripheral Neuropathy Drug, Near 10% Stake in Solasia
December 11, 2019
- Chugai Expanding Target Range, MOAs in Antibody Drug Discovery with Its Engineering Technologies
December 11, 2019
- 1st Patient Dosed in Japan PII for Daiichi Sankyo’s ATL Drug
December 11, 2019
- Nobelpharma’s Retympa, Senju’s Aibeta Now Available
December 11, 2019
- Healios Poised to Go into the Black with Sakigake-Designated MultiStem, Revs Up Universal Cell Biz
December 10, 2019
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…